Clinical Trials Logo

Hypertrophic Surgical Scar clinical trials

View clinical trials related to Hypertrophic Surgical Scar.

Filter by:
  • None
  • Page 1

NCT ID: NCT06033430 Recruiting - Hypertrophic Scar Clinical Trials

Effectiveness of Dry Needling in Linear Scar Tissue

Start date: October 10, 2023
Phase: N/A
Study type: Interventional

Scar tissue can cause serious complications that significantly impact a patient's quality of life. Common complications include stiffness and contractions, which can restrict joint mobility and make daily activities challenging. In severe cases, these limitations can even prevent patients from fulfilling their work responsibilities or engaging in activities they enjoy. The deleterious effect of scar tissue on a patient's well-being is of utmost significance. However, several therapeutic approaches have been proposed to manage scar tissue complications. Enhancing scar tissue compliance can help patients regain their functional abilities and reduce limitations. One such approach is dry needling, a technique used to improve the flexibility of myofascial tightness. Nevertheless, the effectiveness of dry needling in improving scar tissue compliance remains debatable. Therefore, this study aims to investigate the therapeutic effects of dry needling on complications resulting from linear hypertrophic scars caused by surgery or trauma.

NCT ID: NCT04951869 Completed - Clinical trials for Keloid Scar Following Surgery

: Protescal: Prevention of Hypertrophic Scar and Keloid Formation Post Caesarean Section

Start date: April 26, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

This study aimed to evaluate the effectiveness of Protescal in preventing post caesarean section hypertrophic scar and keloid formation.

NCT ID: NCT01689857 Completed - Clinical trials for Hypertrophic Surgical Scar

Clinical Trial to Evaluate the Safety and Efficacy of Scarclinic™ Thin in Surgical Scars

Start date: October 2010
Phase: N/A
Study type: Interventional

Compare the efficacy and safety of Scarclinic™Thin and Scarclinic™ Normal for the treatment of surgical scars. Participant: 40 Treatment period : 3 months Medical device: Scarclinic™Thin , Scarclinic™ Normal Randomization: Table of random number